TRUFILL DCS ORBIT 637HF0204Recalls & reported problems
Cerenovus, Inc. · TRUFILL DCS ORBIT Detachable Coil 175cm 2mm x 4cm Coil Type: Helical Fill · Class 2 · Implant
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10886704029663), received between Mar 3, 2017 and Mar 3, 2017 — classified as 1 malfunction.
The most frequently reported specific device problem is “Stretched” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Stretched1
Patient problems
- No Consequences Or Impact To Patient1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionMar 3, 2017Stretched; Stretched
IT WAS REPORTED BY THE HEALTH CARE PROFESSIONAL THAT DURING COIL EMBOLIZATION AT THE ANTERIOR COMMUNICATING ARTERY RESISTANCE WAS EXPERIENCED WHEN USING AN ORBIT HELICAL 2 X 4 COIL AND THE COIL WAS FOUND TO BE STRETCHED. THE COIL COULD NOT BE INSERTED INTO THE HUB OF THE MICROCATHETER; THE COIL WAS WITHDRAWN FROM THE MICROCATHETER AND WAS FOUND TO BE STRETCHED. THE COMPLAINT COIL WAS REMOVED FROM THE MICROCATHETER STILL ATTACHED TO THE DELIVERY SYSTEM, THE REPORTED EVENT DID NOT REQUIRE REMOVAL OF THE CATHETER. A NEW COIL WAS USED TO COMPLETE THE PROCEDURE. PRIOR TO THE COMPLAINT COIL OTHER COILS WERE SUCCESSFULLY USED WITH THE SAME MICROCATHETER. AN ADEQUATE CONTINUOUS FLUSH WAS MAINTAINED THROUGH THE CATHETER. THERE WERE NO INTRA OR POST PROCEDURAL COMPLICATIONS OR SURGICAL DELAYS RELATED TO DEVICE OR REPORTED EVENT. THERE WERE NO DAMAGES NOTED ON THE COMPLAINT COIL PRIOR TO USE. THERE WAS NO REPORT ON THE PATIENT INJURY. IT WAS INITIALLY REPORTED THAT THE COMPLAINT COIL IS AVAILABLE FOR RETURN.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6376157 ↗
Other DEVICE, NEUROVASCULAR EMBOLIZATION devices
- POD RBYPODJ60-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION355 reports
- Penumbra System SCH1Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION295 reports
- RUBY Coil RBY4C0860-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION276 reports
- Smart Coil 400SMTHXSFT0208Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION165 reports
- Penumbra System RH1-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION154 reports
- Optima Coil System OPTI0208CSS10Balt USA LLC · Device, Neurovascular Embolization3 recalls3 reports
- POD RBYPOD6-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION148 reports
- POD RBYPODJ30-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION132 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page